SMD 3117Alternative Names: SMD-3117
Latest Information Update: 16 Nov 2016
At a glance
- Originator Sirenas Marine Discovery
- Class Antineoplastics; Auristatins; Immunotoxins
- Mechanism of Action Cell division inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 20 Oct 2016 Preclinical trials in Cancer in USA (Parenteral)